Feasibility and acceptability of the menstrual cup for non-surgical management of vesicovaginal fistula among women at a health facility in Ghana

Gabriel Y K Ganyaglo, Nessa Ryan, Joonhee Park, A T Lassey, Gabriel Y K Ganyaglo, Nessa Ryan, Joonhee Park, A T Lassey

Abstract

Objective: To assess the feasibility of the menstrual cup for short-term management of urinary leakage among women with vesicovaginal fistula (VVF).

Methods: A repeated measures design compared volume of leakage with and without the cup via a 2-hr pad test among women with VVF seeking surgical repair at a health facility in Ghana. Subsequently a gynecological exam was administered to assess safety outcomes, followed by a questionnaire to assess acceptability and perceived efficacy. A paired t-test was used to analyze reduction of leakage in ml, and percent reduction was reported. Study limitations include observer bias while evaluating adverse outcomes and the possibility of social desirability bias during questionnaire administration that might overestimate the effect of the cup and women's acceptability.

Results: Of the 32 patients screened, 11 were eligible (100% consent rate). At baseline, mean (±SD) leakage in ml was 63.2 (±49.2) (95% CI: 30.2-96.3) over two hours, while the mean leakage over two hours of use of the cup was 16.8 (±16.5) (95% CI: 5.7-27.9). The mean difference of 46.4 (±52.1) ml with use of the cup (95% CI: 11.4-81.4) was statistically significant (p = 0.02). With the cup, women experienced an average 61.0% (±37.4) (95% CI: 35.9-86.2) leakage reduction, a difference 10/11 users (91.0%) perceived in reduced leakage. One participant, reporting four previous surgical attempts, experienced a 78.7% leakage reduction. Acceptability was high-women could easily insert (8/11), remove (8/11), and comfortably wear (11/11) the cup and most (10/11) would recommend it. No adverse effects attributable to the intervention were observed on exam, although some women perceived difficulties with insertion and removal. Data collection tools were appropriate with slight modification advised.

Conclusion: A larger trial is warranted for a more robust evaluation of the menstrual cup for management of urinary leakage due to VVF among women who have not yet accessed surgery or for whom surgery was not successful.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Study flow chart.
Fig 1. Study flow chart.
The mean (±SD) volume of urine leaked over two hours at baseline was 63.2 (±49.2) ml (95% CI: 30.2–96.3). Most participants self-reported usually changing their cloth more than three times daily, with half (5/11) reporting five or more times (Table 3). The Shapiro-Wilks test suggests that the assumption of normal distribution is not rejected for observed baseline leakage (W = 0.94; critical threshold = 0.85).

References

    1. Wall L. Obstetric vesicovaginal fistula as an international public-health problem. Lancet. 2006;368 (9542): 1201–1209.
    1. De Ridder D. Vesicovaginal fistula: a major healthcare problem. Curr Opin Urol. 2009;19(4): 358–361.
    1. Tebeu PM, Fomulu JN, Khaddaj S, de Bernis L, Delvaux T, Rochat CH. Risk factors for obstetric fistula: a clinical review. Int Urogynecol J. 2012;23(4): 387–394.
    1. Ghana Health Service. Report on Fistula Report Burden in Ghana. 2015.
    1. Polan ML, Sleemi A, Bedane MM, Lozo S, Morgan MA. Obstetric Fistula In: Debas HT, Donkor P, Gawande A, Jamison DT, Kruk ME, Mock CN, editors. Essential Surgery. Washington, DC: World Bank; 2015.
    1. Baker Z, Bellows B, Bach R, Warren C. Barriers to obstetric fistula treatment in low-income countries: a systematic review. Trop Med Int Health. 2017;22(8): 938–959.
    1. Arrowsmith SD, Barone MA, Ruminjo J. Outcomes in obstetric fistula care: a literature review. Curr Opin Obstet Gynecol. 2013;25: 399–403.
    1. Mwini-Nyaledzigbor PP, Agana AA, Pilkington FB. Lived experiences of Ghanaian women with obstetric fistula. Health Care Women Int. 2013;34(6): 440–60.
    1. Beksinska ME, Smit J, Greener R, Todd CS, Lee ML, Maphumulo V, Hoffmann V. Acceptability and performance of the menstrual cup in South Africa: a randomized crossover trial comparing the menstrual cup to tampons or sanitary pads. J Womens Health. 2015;24(2): 151–158.
    1. Russell KW, Robinson RE, Mone MC, Scaife CL. Enterovaginal or vesicovaginal fistula control using a silicone cup. Obstet Gynecol. 2016;128(6): 1365–1368.
    1. Goldberg L, Elsamra S, Hutchinson-Colas J, Segal S. Delayed diagnosis of vesicouterine fistula after treatment for mixed urinary incontinence: menstrual cup management and diagnosis. Female Pelvic Med Reconstr Surg. 2016;22: e29–e31.
    1. Vision Reporter. Menstrual cup: temporary relief for fistula patients. in New Vision. 2012.
    1. Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, et al., A tutorial on pilot studies: the what, why and how. BMC Medical Research Methodology. 2010;10(1): 1–10.
    1. NIH U.S. National Library of Medicine. FDAAA 801 and the Final Rule.
    1. Goh JT. A new classification for female genital tract fistula. Aust N Z J Obstet Gynaecol. 2004; 44(6): 502–4.
    1. Juma J, Nyothach E, Laserson KF, Oduor C. Arita L, Ouma C et al. Examining the safety of menstrual cups among rural primary school girls in western Kenya: observational studies nested in a randomised controlled feasibility study. BMJ Open. 2017;7(4).
    1. NCAA. A factsheet for student athletes: assess your hydration status. 2017.
    1. Bowen DJ, Kreuter M, Spring B, Cofta-Woerpel L, Linnan L, Weiner D, et al. How we design feasibility studies. American Journal of Preventive Medicine. 2009;36(5):452–457.
    1. Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C. Fourth international consultation on incontinence recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn. 2010;29: 213–40.
    1. StataCorp. 2013. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP.
    1. Tellier S, Hyttel M. Menstrual health management in east and southern Africa: a review paper. United Nations Population Fund, WoMena. 2018.
    1. Sullivan G, O’Brien B, Mwini-Nyaledzigbor PP. Sources of support for women experiencing obstetric fistula in northern Ghana: a focused ethnography. Midwifery. 2016;40: 162–168.
    1. United Nations. Report of the secretary general: supporting efforts to end obstetric fistula. 2014.
    1. Pope R, Bangser M, Requejo JH. Restoring dignity: social reintegration after obstetric fistula repair in Ukerewe, Tanzania. Global Public Health. 2011;6(8): 859–873.

Source: PubMed

3
購読する